Quantcast

Latest Non-steroidal anti-inflammatory drugs Stories

2014-07-08 08:31:53

DUBLIN, July 8, 2014 /PRNewswire/ -- Perrigo Company (NYSE: PRGO; TASE) today announced that it was the first to receive final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for ibuprofen and phenylephrine hydrochloride tablets, 200 mg/10 mg (over-the-counter), the store brand equivalent to Advil(®) Congestion Relief Tablets, 200 mg/10 mg. Perrigo expects to begin shipments of the product prior to the upcoming cough/cold/flu season....

2014-07-01 08:31:24

· quellin(TM) (carprofen) soft chewable tablets help veterinarians alleviate the pain associated with canine osteoarthritis SHAWNEE, Kan., July 1, 2014 /PRNewswire/ -- Bayer HealthCare LLC Animal Health is pleased to announce the launch of quellin(TM) (carprofen) soft chewable tablets to help alleviate the pain associated with canine osteoarthritis, one of the most common causes of chronic pain in dogs--affecting 20 percent of dogs older than one year of age.(1) quellin(TM), the...

2014-06-25 08:30:55

GREENWOOD VILLAGE, Colo., June 25, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that it has informed the Transplant and Ophthalmology Division of the FDA of its intent to reduce the patient sample size in the OptimEyes Study for the treatment of Diabetic Macular Edema (oral treatment with Optina(TM)). This trial was intended to enroll 450 patients and was powered at 95%. The present enrollment of over 355 patients provides an adequate power of 88%,...

2014-06-19 12:24:02

DUBLIN, June 19, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/twpmjd/global_and) has announced the addition of the "Global and Chinese Methyl Salicylate Industry Report 2014" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The Global and Chinese Methyl Salicylate Industry Report 2014 is a professional and in-depth study on the current state of the global Methyl Salicylate industry with a focus on the Chinese situation....

2014-06-18 08:28:42

NEWARK, Calif., June 18, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the JMP Securities 2014 Healthcare Conference in New York City. The presentation at the JMP conference is scheduled for 11:30 am ET (8:30 am PT) on Tuesday June 24, 2014. The presentation will be webcast, and the webcast can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A recording of the webcast will be archived for 30...

2014-06-10 08:30:40

NEWARK, Calif., June 10, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the Wells Fargo 2014 Healthcare Conference in Boston. The presentation at the Wells Fargo conference is scheduled for 3:35 pm ET (12:35 pm PT) on Wednesday June 18, 2014. The presentation will be webcast, and the webcast can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A recording of the webcast will be archived for 30...

2014-06-06 23:00:28

DeepResearchReports.com adds “2014 Deep Research Report on Global and China Methyl Salicylate Industry” and “2014 Deep Research Report on Global and China Methyl Bromide Industry” reports to its research store. Dallas, Texas (PRWEB) June 07, 2014 "2014 Deep Research Report on Global and China Methyl Salicylate Industry” is a professional and in-depth research report on the Global and China methyl salicylate market. The report provides basic methyl salicylate information,...

2014-06-03 08:28:25

MADISON, Tenn., June 3, 2014 /PRNewswire/ -- More and more athletes seeking optimal performance are saying "no" to non-steroidal anti-inflammatory drugs (NSAIDs) and switching to safe, non-toxic AminoActiv® (http://aminoactiv.com/), which not only relieves pain and inflammation but also adds performance-related benefits. Photo - http://photos.prnewswire.com/prnh/20140602/93454 Photo - http://photos.prnewswire.com/prnh/20140602/93455 Product Manager Don Raymond says that AminoActiv should be...

2014-05-29 08:29:40

MISSISSAUGA, ON, May 29, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products today announced that a third party has received U.S. Food and Drug Administration (FDA) approval to market and sell a topical diclofenac sodium 1.5% solution in the United States. The product is a generic version of Nuvo's PENNSAID (diclofenac sodium topical solution) 1.5% w/w (PENNSAID 1.5%). Mallinckrodt Inc. (NYSE:MNK)...

FDA Approves Several Drugs That Predictably Increase Risk For Heart And Stroke
2014-05-28 03:41:30

By Jeannette Spalding, Case Western Reserve University The agency charged to protect patients from dangerous drug side effects needs to be far more vigilant when it comes to medications that affect blood pressure. Robert P. Blankfield, MD, MS, a clinical professor of family medicine, issues this call to the U.S. Food and Drug Administration (FDA) in an editorial published recently in an online edition of the Journal of Cardiovascular Pharmacology and Therapeutics; the print version of...


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related